231 related articles for article (PubMed ID: 27147961)
1. Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review.
Zhao T; Hong Y; Li XJ; Li SH
Front Mol Neurosci; 2016; 9():27. PubMed ID: 27147961
[TBL] [Abstract][Full Text] [Related]
2. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.
Zhao T; Hong Y; Li S; Li XJ
J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006
[TBL] [Abstract][Full Text] [Related]
3. Role of TFEB in Huntington's Disease.
Ojalvo-Pacheco J; Yakhine-Diop SMS; Fuentes JM; Paredes-Barquero M; Niso-Santano M
Biology (Basel); 2024 Apr; 13(4):. PubMed ID: 38666850
[TBL] [Abstract][Full Text] [Related]
4. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
5. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
Liu Y; Hettinger CL; Zhang D; Rezvani K; Wang X; Wang H
J Neurochem; 2014 May; 129(3):539-47. PubMed ID: 24383989
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-modifying enzymes in Huntington's disease.
Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA
Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679
[TBL] [Abstract][Full Text] [Related]
8. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
11. Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.
Fiorillo A; Morea V; Colotti G; Ilari A
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945781
[TBL] [Abstract][Full Text] [Related]
12. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
Fu Y; Sun X; Lu B
Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling.
Chang CC; Lin TC; Ho HL; Kuo CY; Li HH; Korolenko TA; Chen WJ; Lai TJ; Ho YJ; Lin CL
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149534
[TBL] [Abstract][Full Text] [Related]
14. Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
Tong H; Yang T; Xu S; Li X; Liu L; Zhou G; Yang S; Yin S; Li XJ; Li S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612657
[TBL] [Abstract][Full Text] [Related]
15. miR-302 Attenuates Mutant Huntingtin-Induced Cytotoxicity through Restoration of Autophagy and Insulin Sensitivity.
Chang CC; Tsou SH; Chen WJ; Ho YJ; Hung HC; Liu GY; Singh SK; Li HH; Lin CL
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445125
[TBL] [Abstract][Full Text] [Related]
16. Siah-1-interacting protein regulates mutated huntingtin protein aggregation in Huntington's disease models.
Latoszek E; Wiweger M; Ludwiczak J; Dunin-Horkawicz S; Kuznicki J; Czeredys M
Cell Biosci; 2022 Mar; 12(1):34. PubMed ID: 35305696
[TBL] [Abstract][Full Text] [Related]
17. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
18. Dopamine exacerbates mutant Huntingtin toxicity via oxidative-mediated inhibition of autophagy in SH-SY5Y neuroblastoma cells: Beneficial effects of anti-oxidant therapeutics.
Vidoni C; Castiglioni A; Seca C; Secomandi E; Melone MA; Isidoro C
Neurochem Int; 2016 Dec; 101():132-143. PubMed ID: 27840125
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
[TBL] [Abstract][Full Text] [Related]
20. PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An
Carnemolla A; Michelazzi S; Agostoni E
Front Cell Neurosci; 2017; 11():121. PubMed ID: 28533744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]